Nachrichten/Concert Pharmaceuticals Says its Alopecia Areata Investigational…Concert Pharmaceuticals Says its Alopecia Areata Investigational Drug CTP-543 Met Phase 3 Trial Endpoints23. Mai 202211:44 UTCCCNCE